Bernard Maybury

7PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional, complementary and integrative medicine not elsewhere classifiedHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Oct 29, 2025
Common Themes and Uncertainties in Management of Secondary Polycythaemia: An International Clinician Survey of Practice.

Phillip Lr Nicolson, Midhat Asif, Richard J Buka

|Oct 09, 2025
An evaluation of a real-world, multi-disciplinary, treatment-free remission programme for patients with Chronic Myeloid Leukaemia.

Eleanor Jones, Joanne Ewing, Hayder Hussein

|Jul 01, 2025
Venesection and resolution of erythrocytosis are not associated with reduced thrombotic risk in secondary and idiopathic polycythaemia: Results from a dual centre, 5-year retrospective study.

B D Maybury, E Jongman, C Morgan

|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.

Sridhar Chaganti, Christopher P Fox, Bernard D Maybury

|Apr 22, 2024
Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival.

Bernard D Maybury, Lisa James, Neil Phillips

Pageof 2

Frequent Collaborators

2 joint publications

Phillip Lr Nicolson

2 joint publications

Richard J Buka

1 joint publications

E Jongman

1 joint publications

C Morgan